There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Humacyte , Eledon Pharmaceuticals and Nyxoah with bullish sentiments. Claim 70% Of ...
Mirum Pharmaceuticals MIRM announced that it has completed enrollment in the phase III EXPAND study, which evaluated Livmarli (maralixibat) for treating cholestatic pruritus in patients aged six ...
In a report released yesterday, Vamil Divan from Guggenheim reiterated a Buy rating on ANI Pharmaceuticals, with a price target of $124.00. The company’s shares closed yesterday at $72.17. Divan ...
ASX healthcare stocks remain under pressure, but strong clinical and regulatory catalysts are still driving standout gains across the sector. ... Read More The post Scott Power: Conflict, inflation ...
Investor's Business Daily on MSN
Two biotech stocks hover near highs; natural gas and finance names show resilience
Two biotech stocks, Ligand Pharmaceuticals and United Therapeutics, are showing resilient action in Friday's stock market.
Zacks Small Cap Research on MSN
CING: Laying the foundation for 1H:27 launch
By John Vandermosten, CFA NASDAQ: CING READ THE FULL CING RESEARCH REPORT Cingulate, Inc. (NASDAQ: CING) reported 2025 results on March 18th, 2026. The company generated no revenue and recorded ...
Dan Yoo took a breath before describing what he saw when he stopped into work on a Sunday morning at the Larry C. Hardy ...
Robust financial performance driven by full year 2025 royalty revenue growth of 48% Reiterating 2026 financial guidance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results